Navigation Links
Cephalon Reported Financial Results for the Second Quarter of 2011
Date:8/2/2011

exclude the change in fair value of the Ception Therapeutics, Inc. ($1.4M), BioAssets Development Company ($0.3M) and Gemin X Pharmaceuticals ($0.9M) contingent consideration.(5) To exclude costs related to restructurings.(6) In 2011, to exclude costs related to the impairments of AMRIX ($43.3M) and Mepha in-process research and development ($5.2M). (7) To exclude imputed interest expense associated with convertible debt.(8) In 2011, to exclude the change in fair value of our investments in Mesoblast Ltd. ($91.2M) and ChemGenex Pharmaceuticals Ltd. ($8.3M). (9) In 2011, to exclude costs and changes in fair value of certain derivative contracts ($16.5M).  In 2010, to exclude losses related to the acquisition of Mepha AG, including a loss on foreign exchange derivative instruments ($2.9M) and a loss on foreign exchange of Swiss Franc acquisition funds ($2.5M). (10) To reflect the tax effect of pre-tax adjustments at applicable tax rates and certain other tax adjustments primarily related to changes in valuation allowances and other changes in tax assets and liabilities.CEPHALON, INC. AND SUBSIDIARIESReconciliation of GAAP Net Income to Adjusted Net Income Attributable to Cephalon, Inc.(Unaudited)Six Months EndedJune 30,20112010GAAP NET INCOME ATTRIBUTABLE TO CEPHALON, INC.

$ 329,263$ 199,629Cost of sales adjustments

28,284

(1)

83,175

(1)Research and development adjustments

320

(2)

676

(2)Selling, general and administrative adjustments

25,704

(3)

11,502

(3)Change in fair value of contingent consideration adjustments

4,401

(4)

-Restructuring adjustment

5,137

(5)

5,325

(5)Acquired in-process research and development adjustments

30,000

(6)

-Impairment and (gain) loss on sale of assets adjustment

54,056

(7)

-Interest expense adjustment

31,691

(8)

36,055

(8)Chan
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Cephalon Quarterly Conference Call Invitation
2. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
3. $425 Million Cephalon Civil Settlement and Criminal Fine; In Americas Largest
4. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
5. Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
6. Cephalon Reports Another Strong Quarter
7. Cephalon, Inc. to Webcast Analyst Day
8. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
9. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
10. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
11. Cephalons New Product Launches Pace Record 2008 Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... York (PRWEB) August 29, 2014 ... at $5.6 billion in 2019. It is expected ... 2013 to 2019, and was valued at $1.8 ... published by Transparency Market Research. , For more ... http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research report, titled ...
(Date:8/29/2014)... 29, 2014 Local veterinarian, Dr. Keith ... are seeking candidates to participate in an investigational study ... The ultimate goal of this study is to determine ... one or two arthritically affected joints can help reduce ... Candidates for the current investigational study must be older ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Intrinsic ... 13485:2003 certified, GAMP® 5 compliant imaging core lab, ... international Phase II clinical trial to assess a ... Throughout this trial, Intrinsic Imaging will provide comprehensive ... to, protocol and charter development, site qualification, site ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and ... 150 ppb,” said Mark Tess, PhD, Mycotoxin Product Manager for ... owners and USDA-GIPSA inspection agencies that have a need to ... place in a matter of minutes with nothing but our ... feed and grain before accepting it, but they no longer ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2
... Sept. 21 Mr. Paw Yew Hock, the newly appointed Interim ... Ltd.)("China Agro") announced today the reorganization of the Company in order ... biotech marketplaces. , , Mr. Paw noted that ... Company has put in place a seasoned board and management team, ...
... , WORCESTER, Mass., Sept. 21 ... Dr. Robert Lanza, its Chief Scientific Officer, will be featured ... an hour long radio program on science, technology, politics, and ... in New York City (WBAI 99.5 FM), and re-aired in ...
... , WEST CONSHOHOCKEN, Pa., Sept. 21 Cadient ... industry, today announced that two web sites it developed and designed have ... magazine,s MM&M Awards for the Best Web Site category. ... web site developed by Cadient Group for AstraZeneca and the ...
Cached Biology Technology:China Agro-Technology Holdings Reorganized 2Dr. Robert Lanza Featured on Michio Kaku's 'Explorations in Science' 2Dr. Robert Lanza Featured on Michio Kaku's 'Explorations in Science' 3Cadient Group Selected as Finalist in Medical Marketing & Media Awards 2
(Date:8/28/2014)... have identified a handful of bacterial culprits that may ... and ulcerative colitis, using patients, own intestinal immune responses ... 28 in the journal Cell . , Trillions ... plays a critical role in the development and progression ... number of bacterial species affect a person,s susceptibility to ...
(Date:8/28/2014)... MD FASEB MARC (Maximizing Access to Research Careers) ... American Society of Human Genetics from October 18 ... are meant to promote the entry of students, post ... of the basic science community and to encourage the ... Human Genetics. This year MARC conferred 16 awards ...
(Date:8/28/2014)... support of peer groups and clinicians is critical ... to recent University of Georgia research. , A ... County area determined that role models for successful ... of infants. , "Mothers who received that support ... said study co-author Alex Anderson, an associate professor ...
Breaking Biology News(10 mins):Yale study identifies possible bacterial drivers of IBD 2Breastfeeding study shows need for effective peer counseling programs 2
... (June 23, 2009) University of Minnesota Medical School researchers have ... may work to treat those infected by a parasitic flatworm. ... The Schistosomasis parasite infects about 200 million ... 70 countries, where people become infected simply by bathing, drinking, or ...
... indicates the way our brain handles how we move ... someone else,s shoesmay be related to how and why ... recently published in the online scientific journal PLoS ... http://tinyurl.com/lw6qmv . Empathy involves, in part, the ability ...
... Microbiome Project has awarded more than $42 million to expand its ... or on our bodies affect our health, the National Institutes of ... all the microorganisms that reside in or on the human body, ... as part of the NIH Common Fund,s Roadmap for Medical Research, ...
Cached Biology News:U of M study finds new insight on therapy for a devastating parasitic disease 2Ability to literally imagine oneself in another's shoes may be tied to empathy 2Ability to literally imagine oneself in another's shoes may be tied to empathy 3NIH expands Human Microbiome Project; funds sequencing centers and disease projects 2NIH expands Human Microbiome Project; funds sequencing centers and disease projects 3NIH expands Human Microbiome Project; funds sequencing centers and disease projects 4NIH expands Human Microbiome Project; funds sequencing centers and disease projects 5
...
... to MSY2/YBOX2 ( Abpromise for ... Antigen: Synthetic peptide derived from ... of human YBX2. (Note: the ... Entrez ...
... Freedom EVO384R are fast multi-channel pipetting platforms ... different sizes, with a multi-channel head and ... time saving, with true parallel processing of ... your assays with the Freedom EVOware program. ...
... Aminopropylsilane is perhaps the ... chemistry for microarray experiments. ... for Microarrays provide a ... for printing PCR products ...
Biology Products: